Critical Role of Monocyte Chemoattractant Protein-1/CC Chemokine Ligand 2 in the Pathogenesis of Ischemic Cardiomyopathy

Background— Cardiac interstitial fibrosis plays an important role in the pathogenesis of ischemic cardiomyopathy, contributing to systolic and diastolic dysfunction. We have recently developed a mouse model of fibrotic noninfarctive cardiomyopathy due to brief repetitive myocardial ischemia and reperfusion. In this model, fibrotic changes are preceded by marked and selective induction of the CC chemokine monocyte chemoattractant protein-1 (MCP-1). We hypothesized that MCP-1 may mediate fibrotic remodeling through recruitment of mononuclear cells and direct effects on fibroblasts. Methods and Results— Wild-type (WT) and MCP-1-null mice underwent daily 15-minute coronary occlusions followed by reperfusion. Additional WT animals received intraperitoneal injections of a neutralizing anti-MCP-1 antibody after the end of each ischemic episode. Hearts were examined echocardiographically and processed for histological and RNA studies. WT mice undergoing repetitive brief myocardial ischemia and reperfusion protocols exhibited macrophage infiltration after 3 to 5 days and marked interstitial fibrosis in the ischemic area after 7 days, accompanied by ventricular dysfunction. MCP-1-null mice had markedly diminished interstitial fibrosis, lower macrophage infiltration, and attenuated ventricular dysfunction compared with WT animals. MCP-1 neutralization also inhibited interstitial fibrosis, decreasing left ventricular dysfunction and regional hypocontractility. Cardiac myofibroblasts isolated from WT but not from MCP-1-null animals undergoing repetitive myocardial ischemia and reperfusion demonstrated enhanced proliferative capacity. However, MCP-1 stimulation did not induce cardiac myofibroblast proliferation and did not alter expression of fibrosis-associated genes. Conclusions— Defective MCP-1 signaling inhibits the development of ischemic fibrotic cardiomyopathy in mice. The profibrotic actions of MCP-1 are associated with decreased macrophage recruitment and may not involve direct effects on cardiac fibroblasts.

[1]  Xiaofeng Zhu,et al.  Diminished induction of skin fibrosis in mice with MCP-1 deficiency. , 2006, The Journal of investigative dermatology.

[2]  J. Dranoff,et al.  Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[3]  S. Kaneko,et al.  MCP‐1/CCR2‐dependent loop for fibrogenesis in human peripheral CD14‐positive monocytes , 2006, Journal of leukocyte biology.

[4]  F. Villarreal,et al.  The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[5]  M. Entman,et al.  Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts , 2005, Circulation.

[6]  B. Rollins,et al.  CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts , 2005, Circulation research.

[7]  T. Moore,et al.  CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. , 2005, The American journal of pathology.

[8]  K. Weber,et al.  Animal models of cardiac fibrosis. , 2005, Methods in molecular medicine.

[9]  N. Frangogiannis.  Chemokines in the ischemic myocardium: from inflammation to fibrosis , 2004, Inflammation Research.

[10]  I. Charo,et al.  Chemokines in the pathogenesis of vascular disease. , 2004, Circulation research.

[11]  A. Takeshita,et al.  Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[12]  Shawn Cowper,et al.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood. , 2004, The international journal of biochemistry & cell biology.

[13]  M. Entman,et al.  Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. , 2004, The American journal of pathology.

[14]  N. Frangogiannis,et al.  The pathological basis of myocardial hibernation. , 2003, Histology and histopathology.

[15]  J. Crapo,et al.  Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Peters-Golden,et al.  Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[17]  M. Entman,et al.  Active interstitial remodeling: an important process in the hibernating human myocardium. , 2002, Journal of the American College of Cardiology.

[18]  M. Entman,et al.  Evidence for an active inflammatory process in the hibernating human myocardium. , 2002, The American journal of pathology.

[19]  T. Borg,et al.  Differential integrin expression by cardiac fibroblasts from hypertensive and exercise-trained rat hearts. , 2002, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[20]  M. Entman,et al.  Brief murine myocardial I/R induces chemokines in a TNF-alpha-independent manner: role of oxygen radicals. , 2001, American journal of physiology. Heart and circulatory physiology.

[21]  M. Entman,et al.  Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia. , 2001, The American journal of pathology.

[22]  J. Ward,et al.  Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. , 2000, Blood.

[23]  Toshiyuki Yamamoto,et al.  Monocyte Chemoattractant Protein-1 Enhances Gene Expression and Synthesis of Matrix Metalloproteinase-1 in Human Fibroblasts by an Autocrine IL-1α Loop1 , 2000, The Journal of Immunology.

[24]  T. Yamamoto,et al.  Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. , 2000, Journal of immunology.

[25]  M. Verani,et al.  Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. , 1999, Circulation.

[26]  B. Rollins,et al.  Monocyte chemoattractant protein-1. , 1999, Chemical immunology.

[27]  K. Weber,et al.  Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones. , 1998, Annals of medicine.

[28]  C. Orosz,et al.  Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. , 1998, The American journal of pathology.

[29]  D. Salant,et al.  RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis , 1997, The Journal of experimental medicine.

[30]  J. Paulauskis,et al.  Differential screening identifies genetic markers of monocyte to macrophage maturation , 1996, Journal of leukocyte biology.

[31]  S. Phan,et al.  Costimulation of Fibroblast Collagen and Transforming Growth Factor β1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific Receptors* , 1996, The Journal of Biological Chemistry.

[32]  T. Standiford,et al.  A role for C‐C chemokines in fibrotic lung disease , 1995, Journal of leukocyte biology.

[33]  C A Beltrami,et al.  Structural basis of end-stage failure in ischemic cardiomyopathy in humans. , 1994, Circulation.

[34]  K. Matsushima,et al.  Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line , 2022 .